Westlake Chemical Partners Lp's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Westlake Chemical Partners Lp (WLKP) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Westlake Chemical Partners Lp vs Its Competitors
- TTM: Trailing 12-month revenue of 1,235M vs 70,089M combined for tracked competitors (1.7% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-3.8% annualized vs trailing 12 months), vs accelerating (+12.4%) for its tracked peer group.
- Growth: Westlake Chemical Partners Lp generated 0.0% revenue growth year over year in Q2 2026, vs 13.1% for its tracked competitors combined.
- Profitability: Its 27.7% net margin compares with 6.2% for the peer group.
- Scale: Westlake Chemical Partners Lp ranks #38 of 83 companies by market capitalization in the Chemical Manufacturing industry, holding 0.2% of industry market cap.
- Peer revenue share: Westlake Chemical Partners Lp accounted for 1.5% of combined revenue among its tracked peer group, down from 1.7% a year earlier.
- Peer differentiation: Revenue per employee of $7.97M compares with $1.77M for the peer group (4.5x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
WLKP Sales vs. its Competitors, Q2 2026
Westlake Chemical Partners Lp reported revenue contraction of 0.01 % year on year in Q2 2026, below its competitors' combined revenue growth of 13.06 %.
With a net margin of 27.72 %, Westlake Chemical Partners Lp achieved higher profitability than its competitors (6.20 %).
Westlake Chemical Partners Lp generated 1.49 % of the combined sales of its peer group, down from 1.68 % a year earlier.
Westlake Chemical Partners Lp vs. its Competitors, Q2 2026
Revenue growth, year on year
Net income growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Westlake Chemical Partners Lp and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Westlake Chemical Partners Lp | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (1) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (10) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (7) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Westlake Chemical Partners Lp's competitor groups requires a Commercial License.
For context: the Chemical Manufacturing industry grew revenue 2.6% year over year, combined, vs 0.0% for Westlake Chemical Partners Lp. Westlake Chemical Partners Lp's share of combined industry revenue moved from 0.33% to 0.32%, a loss of 0.01 percentage points.
Westlake Chemical Partners Lp's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Westlake Chemical Partners Lp | Yes | Yes | Yes | - |
| Competitors combined (8) | ||||
| High-Confidence Competitors (2) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 75.00 % (6 of 8) | 28.60 % (2 of 7) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
WLKP Stock Performance relative to its Competitors
WLKP Stock Performance relative to High-Confidence Competitors
WLKP Stock Performance relative to Similar-Size Competitors
WLKP Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Shell Plc | 282.9% | Outperformed |
| 2 | Lyondellbasell Industries N v | 282.9% | Outperformed |
| 3 | Celanese Corporation | 282.9% | Outperformed |
| 4 | Balchem Corp | 282.9% | Outperformed |
| 5 | Huntsman Corporation | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Westlake Chemical Partners Lp's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Westlake Chemical Partners Lp's Comment on Competition and Industry Peers
Publicly Traded Peers of Westlake Chemical Partners Lp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Westlake Chemical Partners Lp | - | 1,234.72 |
| Shell Plc | 286,930.72 | 266,886.00 |
| Willis Towers Watson Plc | 27,458.34 | 10,102.00 |
| Lyondellbasell Industries N v | 18,823.42 | 31,192.00 |
| Westlake Corporation | 8,588.98 | 11,294.00 |
| Balchem Corp | 5,431.50 | 1,085.88 |
| SUBTOTAL | 355,616.70 | 343,902.80 |
Sign in to see all competitors of Westlake Chemical Partners Lp.
Sources: Westlake Chemical Partners Lp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Westlake Chemical Partners Lp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Westlake Chemical Partners Lp's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Shell Chemical Company | Named by the company | 85% |
| Peer Group | Named by the company | 85% |
| BASF Corporation | Named by the company | 85% |
| LyondellBasell Industries | Named by the company | 85% |
| Motiva Enterprises LLC | Named by the company | 85% |
| Westlake Corporation | Named by the company | 85% |
| Willis Towers Watson Plc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Westlake Chemical Partners Lp's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Westlake Chemical Partners Lp's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Willis Towers Watson Plc | Health Wealth and Career 52.45 % |
| Lyondellbasell Industries N v | Olefins and Polyolefins - Americas 38.37 % |
| Westlake Corporation | Performance and Essential Materials 62.56 % |
| Balchem Corp | Human Nutrition and Health 62.29 % |
| Celanese Corporation | Engineered Materials 56.70 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Westlake Chemical Partners Lp.
Westlake Chemical Partners Lp's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Westlake Chemical Partners Lp | - | 7,965,948 | 2,157,994 |
| Shell Plc | 286,931 | 3,139,835 | 213,165 |
| Willis Towers Watson Plc | 27,458 | 210,021 | 32,765 |
| Lyondellbasell Industries N v | 18,823 | 1,644,280 | -18,239 |
| Westlake Corporation | 8,589 | 773,562 | -81,575 |
| Balchem Corp | 5,431 | 803,166 | 121,608 |
| PEERS TOTAL | 355,617 | 1,772,681 | 86,333 |
Sign in to see all peers for Westlake Chemical Partners Lp.
Westlake Chemical Partners Lp's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Willis Towers Watson Plc | US 40.71 % |
| Balchem Corp | United States 72.25 % |
| Olin Corporation | United States 69.52 % |
| Huntsman Corporation | Asia Pacific 33.59 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Westlake Chemical Partners Lp's Position in Industry Market Structure
Market-capitalization share and concentration across all 79 companies in Westlake Chemical Partners Lp's industry classification, broader than the peer set above. Market cap in millions of $.Westlake Chemical Partners Lp ranks #38 of 79 companies by market capitalization in its industry, holding 0.15 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 2,040, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Linde Plc | 219,273 | 41.56 % |
| 2 | Air Products And Chemicals Inc | 62,106 | 11.77 % |
| 3 | Corteva Inc | 52,070 | 9.87 % |
| 4 | Ppg Industries Inc | 24,013 | 4.55 % |
| 5 | International Flavors and Fragrances Inc | 1,234 | 5.2% |
| 6 | Lyondellbasell Industries N v | 1,234 | 5.2% |
| 7 | Rpm International Inc | 1,234 | 5.2% |
| 8 | Westlake Corporation | 1,234 | 5.2% |
| 9 | Element Solutions Inc | 1,234 | 5.2% |
| 10 | Newmarket Corporation | 1,234 | 5.2% |
| 38 | Westlake Chemical Partners Lp | 803 | 0.15 % |
Market cap and industry share for the rest of Westlake Chemical Partners Lp's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-06-26.
Westlake Chemical Partners Lp's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 33 | Green Plains Inc | 1,251 | 64.20 % |
| 34 | Xpel Inc | 1,188 | 33.39 % |
| 35 | Fmc Corporation | 1,155 | -72.11 % |
| 36 | Ecovyst Inc | 1,113 | 15.45 % |
| 37 | Flotek Industries Inc | 1,234 | 12.3% |
| 38 | Westlake Chemical Partners Lp | 803 | 3.54 % |
| 39 | Kronos Worldwide inc | 1,234 | 12.3% |
| 40 | Lsb Industries Inc | 1,234 | 12.3% |
| 41 | Tronox Holdings Plc | 1,234 | 12.3% |
| 42 | Luxfer Holdings Plc | 1,234 | 12.3% |
| 43 | Valhi inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Westlake Chemical Partners Lp's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-09-28. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Westlake Chemical Partners Lp's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Chemical Manufacturing industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (96 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 31.16 % | 30.74 % (avg) | +0.4 pp |
| Operating Margin | 27.31 % | industry median | +24.3 pp |
| EBITDA Margin | 41.76 % | 3.22 % (avg) | +38.5 pp |
| Capital Intensity (Capex / Revenue) | 4.58 % | 7.98 % (avg) | -3.4 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Westlake Chemical Partners Lp's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 9.60 % | -15.07 % | -11.47 % | 23.62 % | 29.68 % | -25.26 % | -4.61 % | 2.71 % |
| Operating Margin | 27.19 % | 32.07 % | 36.52 % | 32.08 % | 21.82 % | 30.04 % | 34.37 % | 25.81 % |
| Return on Invested Capital | 10.44 % | 10.44 % | 11.00 % | 12.25 % | - | 28.13 % | 13.39 % | 10.57 % |
| P/E | 15.1x | 13.2x | 11.3x | 11.3x | 12.8x | 14.5x | 13.2x | 14.9x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Westlake Chemical Partners Lp's Strategic Group Map
Every company in Westlake Chemical Partners Lp's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Westlake Chemical Partners Lp is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Westlake Chemical Partners Lp's BCG Growth-Share Matrix
Relative market share (vs Westlake Chemical Partners Lp's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Westlake Chemical Partners Lp falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 3.4% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution. A caveat worth reading alongside this chart: Linde Plc alone holds 42% of this industry's market cap. In an industry this dominated by one leader, the framework will place nearly every OTHER company in "Dog" or "Question Mark" purely because relative share is measured against that leader, regardless of how strong those other companies actually are on their own fundamentals. Check the Profitability, Valuation and Financial Strength sections above before treating this quadrant label as a verdict.
Westlake Chemical Partners Lp's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 2,040 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 4.58 % vs industry average 7.98 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Westlake Chemical Partners Lp's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Westlake Chemical Partners Lp's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Westlake Chemical Partners Lp's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Westlake Chemical Partners Lp falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Westlake Chemical Partners Lp's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 24.3 points above the industry median.
- Return on equity 39.3 points above the industry aggregate.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-3.8% annualized vs trailing 12 months).
- Underperforming the U.S.A. 500 over the trailing 12 months.
- Low relative market share vs the industry leader (0.00x).
Opportunities
- A meaningful share of tracked competitors (57.10 %) show financial-distress signals, a possible opening to gain share.
Threats
- Industry dominated by Linde Plc, holding 41.56 % of industry market cap.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Westlake Chemical Partners Lp's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Westlake Chemical Partners Lp | 0.91 | 3.01 | 0.38 |
| Shell Plc | 0.37 | 1.30 | 0.05 |
| Willis Towers Watson Plc | 0.40 | 1.15 | 0.78 |
| Lyondellbasell Industries N v | 0.39 | 1.63 | 1.52 |
| Westlake Corporation | 0.80 | 2.20 | 0.56 |
| Balchem Corp | 0.46 | 2.47 | 0.14 |
Sign in to see all peers for Westlake Chemical Partners Lp.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Westlake Chemical Partners Lp's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Westlake Chemical Partners Lp | Q2 2026 | 0.0 % | -4.0 % |
| Shell Plc | Q4 2025 | -6.1 % | +9.7 % |
| Willis Towers Watson Plc | Q2 2026 | +9.1 % | -30.4 % |
| Lyondellbasell Industries N v | Q2 2026 | +19.8 % | +386.1 % |
| Westlake Corporation | Q2 2026 | +10.8 % | - |
| Balchem Corp | Q2 2026 | +11.2 % | +16.6 % |
| PEERS TOTAL | -5.0 % | +12.9 % |
Sign in to see all peers for Westlake Chemical Partners Lp.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Westlake Chemical Partners Lp's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Westlake Chemical Partners Lp | Q2 2026 | +1.4 % | -48.8 % |
| Shell Plc | Q4 2025 | - | - |
| Willis Towers Watson Plc | Q2 2026 | - | +1.7 % |
| Lyondellbasell Industries N v | Q2 2026 | +3.9 % | -49.9 % |
| Westlake Corporation | Q2 2026 | -2.8 % | -22.5 % |
| Balchem Corp | Q2 2026 | +11.1 % | +59.8 % |
Sign in to see all peers for Westlake Chemical Partners Lp.
Westlake Chemical Partners Lp's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Westlake Chemical Partners Lp | 26.86% | 16.79% | 42.11% |
| Shell Plc | 4.89% | 4.22% | 10.33% |
| Willis Towers Watson Plc | 5.38% | 8.65% | 20.04% |
| Lyondellbasell Industries N v | - | - | - |
| Westlake Corporation | - | - | - |
| Balchem Corp | 9.77% | 10.31% | 12.79% |
Sign in to see all peers for Westlake Chemical Partners Lp.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Westlake Chemical Partners Lp's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Westlake Chemical Partners Lp | 16.97 | - |
| Shell Plc | 16.09 | 1.08 |
| Willis Towers Watson Plc | 18.19 | 2.72 |
| Lyondellbasell Industries N v | - | 0.60 |
| Westlake Corporation | - | 0.76 |
| Balchem Corp | 33.20 | 5.00 |
| PEERS AVERAGE | 20.89 | 1.03 |
Sign in to see all peers for Westlake Chemical Partners Lp.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.